150
Participants
Start Date
January 14, 2019
Primary Completion Date
December 17, 2024
Study Completion Date
December 18, 2027
panitumumab (EGFR inhibitors)
Chemotherapy treatment includes anti-EGFR biologics such as cetuximab or panitumumab, antiangiogenic drugs such as bevacizumab or aflibercept. The indication to treat depends from the presence of CTCs analysed for Ras mutation and HER2 expression
RECRUITING
Natalia Malara, Germaneto
Matteo's Friends
OTHER